ALLIANCE PHARMA (Germany) Technical Analysis
| DVL Stock | EUR 0.40 0.01 2.56% |
As of the 23rd of April, ALLIANCE PHARMA shows the Mean Deviation of 2.06, coefficient of variation of (7,662), and Risk Adjusted Performance of (0.0003). ALLIANCE PHARMA technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate thirteen technical drivers for ALLIANCE PHARMA, which can be compared to its peers. Please confirm ALLIANCE PHARMA treynor ratio, value at risk, and the relationship between the information ratio and maximum drawdown to decide if ALLIANCE PHARMA is priced favorably, providing market reflects its regular price of 0.4 per share.
ALLIANCE PHARMA Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ALLIANCE, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ALLIANCEALLIANCE |
ALLIANCE PHARMA technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
ALLIANCE PHARMA Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of ALLIANCE PHARMA volatility. High ATR values indicate high volatility, and low values indicate low volatility.
ALLIANCE PHARMA Trend Analysis
Use this graph to draw trend lines for ALLIANCE PHARMA. You can use it to identify possible trend reversals for ALLIANCE PHARMA as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual ALLIANCE PHARMA price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.ALLIANCE PHARMA Best Fit Change Line
The following chart estimates an ordinary least squares regression model for ALLIANCE PHARMA applied against its price change over selected period. The best fit line has a slop of 0.0005 , which may suggest that ALLIANCE PHARMA market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.01, which is the sum of squared deviations for the predicted ALLIANCE PHARMA price change compared to its average price change.About ALLIANCE PHARMA Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ALLIANCE PHARMA on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ALLIANCE PHARMA based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on ALLIANCE PHARMA price pattern first instead of the macroeconomic environment surrounding ALLIANCE PHARMA. By analyzing ALLIANCE PHARMA's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ALLIANCE PHARMA's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ALLIANCE PHARMA specific price patterns or momentum indicators. Please read more on our technical analysis page.
ALLIANCE PHARMA April 23, 2024 Technical Indicators
Most technical analysis of ALLIANCE help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ALLIANCE from various momentum indicators to cycle indicators. When you analyze ALLIANCE charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.0003) | |||
| Market Risk Adjusted Performance | 0.2157 | |||
| Mean Deviation | 2.06 | |||
| Coefficient Of Variation | (7,662) | |||
| Standard Deviation | 2.77 | |||
| Variance | 7.68 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (0.40) | |||
| Treynor Ratio | 0.2057 | |||
| Maximum Drawdown | 16.7 | |||
| Value At Risk | (4.35) | |||
| Potential Upside | 4.65 | |||
| Skewness | 0.2222 | |||
| Kurtosis | 0.9903 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in ALLIANCE PHARMA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for ALLIANCE Stock analysis
When running ALLIANCE PHARMA's price analysis, check to measure ALLIANCE PHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ALLIANCE PHARMA is operating at the current time. Most of ALLIANCE PHARMA's value examination focuses on studying past and present price action to predict the probability of ALLIANCE PHARMA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ALLIANCE PHARMA's price. Additionally, you may evaluate how the addition of ALLIANCE PHARMA to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |